127 related articles for article (PubMed ID: 27069125)
1. Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
Hintsala HR; Jokinen E; Haapasaari KM; Moza M; Ristimäki A; Soini Y; Koivunen J; Karihtala P
Anticancer Res; 2016 Apr; 36(4):1497-506. PubMed ID: 27069125
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
[TBL] [Abstract][Full Text] [Related]
4. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
[TBL] [Abstract][Full Text] [Related]
5. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
Isohookana J; Haapasaari KM; Soini Y; Karihtala P
Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas.
Karihtala P; Kauppila S; Soini Y; Arja-Jukkola-Vuorinen
BMC Cancer; 2011 Jun; 11():262. PubMed ID: 21693047
[TBL] [Abstract][Full Text] [Related]
7. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
Chen CS; Tseng YT; Hsu YY; Lo YC
Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
[TBL] [Abstract][Full Text] [Related]
8. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
9. FAM129B-dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells.
Schmidlin CJ; Tian W; Dodson M; Chapman E; Zhang DD
Mol Carcinog; 2021 May; 60(5):331-341. PubMed ID: 33684228
[TBL] [Abstract][Full Text] [Related]
10. The role of Nrf2 in oxidative stress-induced endothelial injuries.
Chen B; Lu Y; Chen Y; Cheng J
J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the Nrf2-Keap1 signaling pathway and its downstream target genes in rat brain under stress.
Djordjevic J; Djordjevic A; Adzic M; Mitic M; Lukic I; Radojcic MB
Brain Res; 2015 Mar; 1602():20-31. PubMed ID: 25598205
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
13. Time course of Keap1-Nrf2 pathway expression after experimental intracerebral haemorrhage: correlation with brain oedema and neurological deficit.
Shang H; Yang D; Zhang W; Li T; Ren X; Wang X; Zhao W
Free Radic Res; 2013 May; 47(5):368-75. PubMed ID: 23438812
[TBL] [Abstract][Full Text] [Related]
14. Keap1-Nrf2 signalling in pancreatic cancer.
Hayes AJ; Skouras C; Haugk B; Charnley RM
Int J Biochem Cell Biol; 2015 Aug; 65():288-99. PubMed ID: 26117456
[TBL] [Abstract][Full Text] [Related]
15. Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
Murtas D; Piras F; Minerba L; Ugalde J; Floris C; Maxia C; Demurtas P; Perra MT; Sirigu P
Oncol Rep; 2010 Feb; 23(2):329-35. PubMed ID: 20043092
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of 8-OHdG and PARK7/DJ-1 in peri-implantitis mucosa.
Kasnak G; Firatli E; Könönen E; Olgac V; Zeidán-Chuliá F; Gursoy UK
Clin Implant Dent Relat Res; 2018 Aug; 20(4):574-582. PubMed ID: 29787640
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
[TBL] [Abstract][Full Text] [Related]
19. Toward clinical application of the Keap1-Nrf2 pathway.
Suzuki T; Motohashi H; Yamamoto M
Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and Nrf2 signaling in McArdle disease.
Kitaoka Y; Ogborn DI; Nilsson MI; Mocellin NJ; MacNeil LG; Tarnopolsky MA
Mol Genet Metab; 2013 Nov; 110(3):297-302. PubMed ID: 23906480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
